Management Summary
A group-level view of inventory health, risk and operational priorities.
Sales Performance
Last 30 Days · 16 Sep – 15 Oct 2026 · compared with previous 30 days
Total Sales
₦18.6M
+8.4%vs previous 30 days
Transactions
4,820
+5.1%vs previous 30 days
Average Transaction Value
₦3,859
+3.1%vs previous 30 days
Units Sold
8,940
+6.7%vs previous 30 days
Sales Trend
16–22 Sep
23–29 Sep
30 Sep–6 Oct
7–13 Oct
14–15 Oct
Partial (2 days)
Weekly sales. The final period (14–15 Oct) is partial.
Sales by Location
| Location | Sales | Share | Change |
|---|---|---|---|
| Lekki | ₦7.81M | 42% of group | +10.2% |
| Ikeja | ₦6.14M | 33% of group | +6.8% |
| Yaba | ₦4.65M | 25% of group | +7.1% |
| Total | ₦18.6M |
Change vs previous 30 days.
Top Categories by Sales
| Category | Sales | % of Total Sales | Change vs previous 30 days | Units Sold |
|---|---|---|---|---|
| Prescription Medicines | ₦7.44M | 40.0% | +10.8% | 2,680 |
| OTC Medicines | ₦4.65M | 25.0% | +7.2% | 2,410 |
| Vitamins & Supplements | ₦2.79M | 15.0% | +12.4% | 1,420 |
| Personal Care | ₦1.86M | 10.0% | +3.8% | 1,060 |
| Medical Supplies | ₦1.12M | 6.0% | -2.6% | 760 |
| Other | ₦744,000 | 4.0% | +1.9% | 610 |
Sales & Inventory Insights
- Prescription Medicines generated 40% of sales (last 30 days) and grew 10.8% vs previous 30 days, making stock availability in this category particularly important.
- Vitamins & Supplements sales increased 12.4% vs previous 30 days, while selected Vitamin D3 inventory remains exposed to expiry risk. Review branch-level stock distribution.
- Medical Supplies sales declined 2.6% vs previous 30 days. Review slow-moving inventory before additional replenishment.
Inventory Position
Current position as of 15 October 2026 · not affected by the reporting period
Inventory Value
₦12.4M
Inventory Units
12,480
Stockout Risks
28
Expiry Risks ≤90 Days
36
Slow-Moving Products
72
Pending Actions
6
Inventory Health
Most inventory is currently healthy, but stock availability and excess/expiry exposure require attention in selected products and locations.
Identified Inventory Exposure
This represents inventory requiring management attention, not confirmed financial loss.
Stock Availability
28
current stockout risks
12
high-priority reorder recommendations
3
branches affected
Availability risk is concentrated in selected fast-moving products rather than across the entire catalogue.
Expiry & Slow-Moving Exposure
36
products expiring within 90 days
72
slow-moving products
₦1.16M
estimated expiry-related value at risk
Location Performance
| Location | Inventory Units | Stockout Risks | Expiry Risks | Slow-Moving | Inventory Health | Management Attention | Action |
|---|---|---|---|---|---|---|---|
| Lekki | 4,180 | 12 | 14 | 25 | Needs Attention | High | View Location |
| Ikeja | 4,760 | 7 | 11 | 28 | Stable | Moderate | View Location |
| Yaba | 3,540 | 9 | 11 | 19 | Needs Attention | High | View Location |
Management Priorities
- 1
Stock Availability
28 products currently show stockout risk across the group, including critical fast-moving items.
Review Stockout Risks - 2
Expiry Risk
36 products are approaching expiry within 90 days. Approximately ₦1.16M of inventory is currently exposed to expiry-related risk.
Review Expiry Risks - 3
Branch Rebalancing
Several products may be better rebalanced between locations before additional purchasing — for example Amlodipine 5mg, 30 packs from Ikeja to Lekki (awaiting review).
Review Transfer Opportunities - 4
Pending Actions
- Reorder recommendations awaiting review2
- Products added to Reorder (no Draft PO yet)0
- Draft POs awaiting approval0
- Approved POs awaiting submission0
- Submitted POs awaiting supplier confirmation0
- Supplier-confirmed orders awaiting delivery0
- Orders in transit0
- Partially received orders requiring follow-up0
- Expiry risks being monitored0
- Expiry risks requiring review5
- Expiry risks with active management actions0
- Transfer recommendations awaiting review4
- Approved transfers awaiting physical execution0
Procurement Status
- 1Recommendations2
- 2Added to Reorder0
- 3Draft POs0
- 4Approved — Awaiting Submission0
- 5Submitted — Awaiting Confirmation0
- 6Supplier Confirmed0
- 7In Transit0
- 8Partially Received0
- 9Received / Closed0
An approved Draft PO does not add stock. Inventory changes only when goods are received.
Stock Transfer Status
Approved transfers do not change actual inventory until physical movement is confirmed.
Management Insights
- Lekki currently has the highest number of stockout risks and may require closer inventory attention.
- Some excess inventory can potentially be redistributed between branches before additional purchases are made.
- Expiry and slow-moving stock represent meaningful working-capital exposure, but the identified value is not equivalent to confirmed loss.
Fictional prototype data · branch-level value and exposure splits are illustrative.